2026 ASCO Breast Cancer Highlights: Triple Negative Breast Cancer

• October 15, 2026

Aptamer Tests Face the Validation Challenge

Clinical adoption will require reproducibility, quality control, and evidence of diagnostic utility

• October 6, 2026

• 3 min

2026 ASCO Breast Cancer Highlights: Food Access, Poverty, and MBC

Harold Burstein, MD, PhD, and Rachel Freedman, MD, MPH discuss the results of a new study looking at the impact of food access and poverty on patients with metastatic breast cancer. They also discuss the new Dana-Farber food pantry and patient navigators who help coordinate care.

• October 15, 2026

• 1 min

Musings From the Power List: Jason Bock

Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development

• by Jason Bock

• October 14, 2026

• 14 min